| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.07▼ | 1.10▼ | 1.10▼ | 1.16▼ | 1.62▼ |
| MA10 | 1.09▼ | 1.12▼ | 1.13▼ | 1.34▼ | 1.98▼ |
| MA20 | 1.12▼ | 1.30▼ | 1.35▼ | 1.65▼ | 2.37▼ |
| MA50 | 1.52▼ | 1.72▼ | 1.78▼ | 2.05▼ | 2.69▼ |
| MA100 | 1.88▼ | 2.08▼ | 2.13▼ | 2.44▼ | 3.36▼ |
| MA200 | 2.25▼ | 2.50▼ | 2.56▼ | 2.63▼ | 22.69▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | 0.004▲ | -0.006▼ | -0.052▼ | -0.137▼ |
| RSI | 22.015▼ | 18.780▼ | 19.459▼ | 12.756▼ | 20.711▼ |
| STOCH | 27.500 | 4.785▼ | 2.809▼ | 3.495▼ | 3.592▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -96.875▼ | -98.551▼ |
| CCI | -162.037▼ | -120.874▼ | -93.388 | -115.742▼ | -181.381▼ |
|
Wednesday, November 18, 2026 06:00 AM
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its ...
|
|
Wednesday, November 18, 2026 04:00 AM
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has entered into an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/11/26 | 1.20 | 1.20 | 1.03 | 1.06 | 32,223 |
| 18/11/26 | 1.14 | 1.194 | 1.05 | 1.15 | 295,216 |
| 17/11/26 | 1.19 | 1.2871 | 1.11 | 1.12 | 33,180 |
| 16/11/26 | 1.25 | 1.3723 | 1.14 | 1.15 | 16,303 |
| 13/11/26 | 1.37 | 1.54 | 1.30 | 1.30 | 13,300 |
| 12/11/26 | 1.56 | 1.60 | 1.35 | 1.35 | 11,470 |
| 11/11/26 | 1.55 | 1.625 | 1.48 | 1.49 | 6,350 |
| 10/11/26 | 1.70 | 1.75 | 1.45 | 1.52 | 7,700 |
| 09/11/26 | 1.64 | 1.7099 | 1.58 | 1.58 | 28,267 |
| 06/11/26 | 1.72 | 1.75 | 1.71 | 1.71 | 8,500 |
|
|
||||
|
|
||||
|
|